Aja Susan, Ewing Cassandra, Lin Jennifer, Hyun Jayson, Moran Timothy H
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 618, Baltimore, MD 21205, USA.
Peptides. 2006 Jan;27(1):157-64. doi: 10.1016/j.peptides.2005.07.003. Epub 2005 Sep 8.
Central administration of both CART and GLP-1 reduces feeding and increases c-Fos in brain areas associated with food intake. To determine whether aspects of CART's effects were mediated through GLP-1's action, we examined whether the GLP-1 receptor antagonist des-His1-Glu9-exendin-4 (EX) blocked CART-induced feeding inhibition, and c-Fos activation. An i.c.v. dose of 100 microg EX blocked the feeding inhibitory action of 1 microg of CART i.c.v. and prevented CART-induced c-Fos expression at multiple hindbrain and hypothalamic sites. These data suggest that i.c.v. CART administration activates a central release of GLP-1 to inhibit feeding and produce widespread neural activation.
向中枢注射CART和GLP-1均可减少进食,并增加与食物摄入相关脑区的c-Fos表达。为了确定CART的某些作用是否通过GLP-1的作用介导,我们研究了GLP-1受体拮抗剂去组氨酸1-谷氨酸9-艾塞那肽-4(EX)是否能阻断CART诱导的进食抑制和c-Fos激活。脑室内注射100微克EX可阻断脑室内注射1微克CART的进食抑制作用,并阻止CART诱导的多个后脑和下丘脑部位的c-Fos表达。这些数据表明,脑室内注射CART可激活GLP-1的中枢释放,从而抑制进食并产生广泛的神经激活。